| Abstrakt: |
Tango Therapeutics, Inc. recently filed a Form 10-Q with the U.S. Securities and Exchange Commission (SEC) on November 6, 2024. This filing provides unaudited financial statements and offers insight into the company's financial position throughout the year. The Form 10-Q is a quarterly report that must be submitted by most reporting companies, and it is due within 45 days of the close of each fiscal quarter. The SEC filing can be accessed for further information on the company's operations and financial status. [Extracted from the article] |
